Indraprastha Medical Corporation Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Near 52-week low — potential value zone (₹342)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
INDRAMEDCO · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% |
| FII | 0.95% | 1.08% | 1.70% | 2.64% | 2.88% | 2.94% |
| DII | 6.36% | 4.91% | 3.14% | 3.19% | 3.18% | 3.56% |
| Public | 41.69% | 43.01% | 44.14% | 43.16% | 42.91% | 42.50% |
Latest News
All newsIndraprastha Gas reports Q1FY26 financial results
*Indraprastha Gas reports Q1FY26 financial results*. The company has filed its financial results for the quarter ended June 30, 2026, with the exchange. Key metrics such as revenue, EBITDA, and net profit will be closely watched by traders for guidance on NGV demand and margin trends. **Figures to be analyzed** for impact on near-term price action. 📊 *STOCKS:* $IGL | 🏢 *SECTOR:* Energy | #MEDIUMIMPACT #Earnings
Indraprastha Medical publishes mandatory corporate notice
*Indraprastha Medical publishes mandatory corporate notice* as part of regulatory compliance. The filing is a routine disclosure with no operational or financial impact. Such notices are standard for listed companies. 📊 *STOCKS:* $IMCL | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #Corporate
Indraprastha Medical Corp to hold shareholders meeting in 2026
*Indraprastha Medical Corp to hold shareholders meeting in 2026.* The company has scheduled the event for September 24, 2026, as per an NSE filing. No details on agenda or special resolutions were disclosed. This is a routine corporate disclosure with no immediate financial implications. 📊 *STOCKS:* IMCL | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #ShareholdersMeeting
Indraprastha Gas to discuss Q1 FY26 results in investor call
*Indraprastha Gas to discuss Q1 FY26 results in investor call.* The company will host a conference call to review its unaudited financial performance for the quarter ended June 30, 2026. This provides clarity on **revenue**, **EBITDA**, and volume trends for retail investors. No new financial data released yet. 📊 *STOCKS:* $IGL | 🏢 *SECTOR:* Energy | #LOWIMPACT #Earnings
About Indraprastha Medical Corporation Limited
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]
HealthcareHealthcare Services